Gilead Sciences Inc
XETRA:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XETRA:GIS
|
US |
|
P
|
Pfizer Inc
XHAM:PFE
|
US |
|
James Hardie Industries PLC
F:JHA
|
IE |
|
Baloise Holding AG
SIX:BALN
|
CH |
|
A
|
Air China Ltd
SWB:AD2
|
CN |
|
W
|
WhiteHorse Finance Inc
F:M9X
|
US |
|
Fibergate Inc
TSE:9450
|
JP |
|
M
|
Martin Marietta Materials Inc
SWB:MMX
|
US |
|
D
|
Dunelm Group PLC
XBER:DFQ
|
UK |
|
C
|
China Shenhua Energy Co Ltd
XHAM:IKF
|
CN |
|
E
|
Ensign Group Inc
F:EGB
|
US |
|
Six Flags Entertainment Corp
F:6FE0
|
US |
|
Schibsted ASA
OSE:SCHA
|
NO |
|
Xinjiang Goldwind Science & Technology Co Ltd
SZSE:002202
|
CN |
|
Mediobanca Banca di Credito Finanziario SpA
OTC:MDIBY
|
IT |
|
J
|
Jones Lang LaSalle Inc
LSE:0JPB
|
US |
|
Figs Inc
NYSE:FIGS
|
US |
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
US |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GIS is 140.93 EUR with a low forecast of 107.64 EUR and a high forecast of 165.11 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
140.93
EUR
According to Wall Street analysts, the average 1-year price target for GIS is 140.93 EUR with a low forecast of 107.64 EUR and a high forecast of 165.11 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.
